675 studies found for:    Open Studies | "Bone Marrow Diseases"
Show Display Options
Rank Status Study
21 Unknown  Arthroplasty Versus Fusion in Anterior Cervical Surgery: Prospective Study of the Impact on the Adjacent Level
Conditions: Clinical Radiculopathy;   Myelopathy Due to a Cervical Disk Disease
Interventions: Device: cervical disc prosthesis with a mobile insert named Mobi-C;   Procedure: arthrodesis - cervical disk surgery
22 Recruiting Baxter: Actifuse SHAPE vs DBX in ACC
Conditions: Cervical Spine Degenerative Disease Nos;   Cervical Spondylosis With Myelopathy
Interventions: Device: Actifuse SHAPE;   Device: Autograft with Demineralized Bone Matrix
23 Unknown  Anesthesia Induction in Patients Undergoing Surgery for Cervical Myelopathy
Condition: Spinal Cord Diseases
Intervention: Drug: anaesthetics: sevofluorane
24 Recruiting A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders
Conditions: Thrombocytosis;   Myeloproliferative Neoplasms
Intervention: Drug: Anagrelide CR
25 Recruiting Raltegravir for HAM/TSP
Conditions: HAM/TSP;   HTLV-1
Intervention: Drug: Raltegravir
26 Unknown  Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Other: Human umbilical cord-derived MSCs;   Other: cyclosporine A  (CsA)
27 Recruiting Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia
Conditions: Primary Myelofibrosis;   Post-polycythemia Vera Myelofibrosis;   Post-essential Thrombocythemia Myelofibrosis
Interventions: Drug: Pacritinib;   Drug: Best Available Therapy
28 Unknown  Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Other: Human umbilical cord-derived MSCs and cyclosporin A;   Other: cyclosporin A
29 Recruiting Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.
Condition: Polycythemia Vera
Interventions: Drug: Best Available Therapy;   Drug: ruxolitinib
30 Not yet recruiting AOP2014 in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.
Condition: Polycythemia Vera
Intervention: Drug: Pegylated-Proline-interferon alpha-2b
31 Recruiting Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia
Conditions: Polycythemia Vera;   Essential Thrombocythemia
Intervention: Drug: Momelotinib
32 Recruiting Lenalidomide and Eltrombopag in Low and Intermediate Risk MDS
Conditions: Myelodysplastic Syndrome;   MDS;   Anemia
Interventions: Drug: Lenalidomide;   Drug: Eltrombopag
33 Unknown  Bortezomib and Low Dose Cytarabine in the Treatment of High-Risk Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: Bortezomib
34 Available Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
Conditions: Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Myelodysplastic Syndrome;   Lymphomas;   Bone Marrow Failure;   Hemoglobinopathy;   Immune Deficiency;   Osteopetrosis;   Cytopenias;   White Blood Cell Abnormalities;   Red Blood Cell Abnormalities
Intervention: Biological: CD34+ enriched, T Cell Depleted donor stem cell product
35 Recruiting Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF
Conditions: Primary Myelofibrosis;   Post-Polycythemic Vera Myelofibrosis;   Post-Essential Thrombocythemia Myelofibrosis
Intervention: Drug: NS-018
36 Recruiting A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Condition: Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive
Interventions: Drug: Bosutinib;   Drug: Imatinib
37 Unknown  F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases
Conditions: Cancer;   Bone Metastases
Interventions: Device: F-18 PET bone scan;   Device: Tc-99m bone scan
38 Recruiting Stem Cell Transplant for Hemoglobinopathy
Conditions: Sickle Cell Disease;   Thalassemia;   Severe Congenital Neutropenia;   Diamond-Blackfan Anemia;   Shwachman-Diamond Syndrome
Interventions: Drug: Busulfan, Fludarabine, ATG, TLI;   Drug: Busulfan, Cyclophosphamide, ATG, GCSF;   Drug: Campath, Fludarabine, Cyclophosphamide;   Radiation: Total Body Irradiation;   Procedure: Stem cell infusion
39 Unknown  Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment
Conditions: Dyskeratosis Congenita;   Fanconi Anemia;   Myelodysplastic Syndromes;   Nonmalignant Neoplasm;   Pearson Marrow-pancreas Syndrome;   Shwachman-diamond Syndrome
Interventions: Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: immunologic technique;   Procedure: biopsy
40 Recruiting Multicenter Study of Magnetic Resonance-guided High Intensity Focused Ultrasound for Pain Palliation of Bone Metastases
Condition: Bone Metastasis
Intervention: Device: MR-HIFU treatment for pain palliation of bone metastases

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years